Related Experiment Videos
Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion
W C Gelderblom1, S Abel, C M Smuts
1Programme on Mycotoxins and Experimental Carcinogenesis, Medical Research Council, Tygerberg, South Africa. wentzel.gelderblom@mrc.ac.za
Abstract:
We review the hepatocarcinogenic effects of fungal cultures of Fusarium verticillioides(= Fusarium moniliforme) strain MRC 826 in male BD IX rats. Subsequent chemical analyses of the fumonisin B (FB) mycotoxin content in the culture material used and long-term carcinogenesis studies with purified FB1 provide information about dose-response effects, relevance of hepatotoxicity during FB1-induced carcinogenesis, and the existence of a no-effect threshold. Fumonisin intake levels of between 0.08 and 0.16 mg FB/100 g body weight (bw)/day over approximately 2 years produce liver cancer in male BD IX rats. Exposure levels < 0.08 mg FB/100 g bw/day fail to induce cancer, although mild toxic and preneoplastic lesions are induced. The nutritional status of the diets used in the long-term experiments was marginally deficient in lipotropes and vitamins and could have played an important modulating role in fumonisin-induced hepatocarcinogenesis. Short-term studies in a cancer initiation/promotion model in rat liver provided important information about the possible mechanisms involved during the initial stages of cancer development by this apparently nongenotoxic mycotoxin. These studies supported the findings of long-term investigations indicating that a cytotoxic/proliferative response is required for cancer induction and that a no-effect threshold exists for cancer induction. The mechanisms proposed for cancer induction are highlighted and include the possible role of oxidative damage during initiation and the disruption of lipid metabolism, integrity of cellular membranes, and altered growth-regulatory responses as important events during promotion.
Insights
Fungal toxins called fumonisins (FB) can cause liver cancer in rats at high doses. A safe threshold exists, as lower FB doses induce lesions but not cancer, suggesting a need for dietary considerations.
Area of Science:
- Toxicology
- Mycotoxicology
- Carcinogenesis
Background:
- Fusarium verticillioides fungal cultures are known to produce mycotoxins.
- Fumonisins (FB) are a class of mycotoxins with potential health risks.
- Understanding the carcinogenic effects of FB is crucial for public health.
Purpose of the Study:
- To investigate the hepatocarcinogenic effects of Fusarium verticillioides.
- To determine dose-response relationships for fumonisin B1 (FB1) induced liver cancer.
- To explore the role of hepatotoxicity and nutritional status in FB1 carcinogenesis.
Main Methods:
- Chemical analysis of FB mycotoxin content in fungal cultures.
- Long-term carcinogenesis bioassays in male BD IX rats.
- Short-term cancer initiation/promotion studies in rat liver models.
Main Results:
- FB intake of 0.08–0.16 mg/100 g body weight/day over 2 years induced liver cancer in rats.
- Exposure below 0.08 mg/100 g bw/day did not cause cancer but induced mild toxic and preneoplastic lesions.
- Nutritional deficiencies in diets may modulate FB-induced hepatocarcinogenesis.
- A cytotoxic/proliferative response is required for cancer induction, with a no-effect threshold.
Conclusions:
- Fumonisins can induce liver cancer in rats, with a clear dose-response relationship.
- A no-effect threshold for fumonisin-induced carcinogenesis exists.
- Mechanisms involve oxidative damage, disrupted lipid metabolism, and altered cellular regulation, influenced by nutritional status.